Welcome to Michigan Psychedelic Center (M-PsyC)
A rigorous, multidisciplinary team focused on psychedelic neuroscience and therapy.
- Center for Consciousness Science
- Center for Drug Repurposing
- Chronic Pain & Fatigue Research Center
- College of Literature, Science, and the Arts
- College of Pharmacy
- Law School
- Life Sciences Institute
- Medical School
- Michigan Institute for Clinical and Health Research
- School of Music, Theater, and Dance
- School of Nursing
- School of Public Health
- School of Social Work
Participate in Our Research: Now Recruiting Subjects
The Mood Disorders Lab at University of Michigan is now recruiting subjects for COMP006, a multicenter, randomized, double-blind, controlled study to investigate the efficacy, safety, and tolerability of two initial administrations of COMP360 in participants with treatment-resistant depression (TRD). This study is a Phase 3 multisite study with COMPASS Pathways, Ltd. looking into efficacy and safety of synthetic Psilocybin for TRD. Those interested in receiving additional information on the study may contact:
- Study Coordinator – Josh Saunders-Lustick, (734) 232-0011, josaunde@med.umich.edu
- Study Coordinator – Megan Rush, (734) 232-0207, megjrush@med.umich.edu
- General Lab Contact – (734) 232-0196, depression-research@med.umich.edu
Our Work
M-PsyC focuses on four areas as related to psychedelic drugs and the psychedelic experience
Education
Research
Therapy
Community Engagement
M-PsyC Highlights
Victoria Powell, MD, receives VA funding to address CLBP
One-third of all veterans have chronic low back pain (CLBP), and veterans with CLBP are twice as likely to have co-occurring depression. With this five-year Career Development Award, Dr. Powell aims to develop an effective ketamine-assisted integrative treatment for veterans with chronic lower back pain and comorbid depression.
Dr. Powell is a VHA palliative care physician, a clinical assistant professor in internal medicine at Michigan Medicine and a member of M-PsyC.
M-PsyC featured as Medicine at Michigan cover story
Through research on psychedelics and chronic pain, treatment of depression with ketamine, and a rigorous academic approach to the topic, our researchers and clinicians are seeking nothing short of expanding our understanding of consciousness and improving patient care.